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Background. Intake of retinoic acid (RA) or of its precursor, vitamin A, during early pregnancy is associated with increased
incidence of craniofacial lesions. The origin of these teratogenic effects remains enigmatic as in cranial neural crest cells
(CNCCs), which largely contribute to craniofacial structures, the RA-transduction pathway is not active. Recent results suggest
that RA could act on the endoderm of the first pharyngeal arch (1stPA), through a RARß-dependent mechanism.
Methodology/Principal Findings. Here we show that RA provokes dramatically different craniofacial malformations when
administered at slightly different developmental times within a narrow temporal interval corresponding to the colonization of
the 1st PA by CNCCs. We provide evidence showing that RA acts on the signalling epithelium of the 1st PA, gradually reducing
the expression of endothelin-1 and Fgf8. These two molecular signals are instrumental in activating Dlx genes in incoming
CNCCs, thereby triggering the morphogenetic programs, which specify different jaw elements. Conclusions/Significance.
The anatomical series induced by RA-treatments at different developmental times parallels, at least in some instances, the
supposed origin of modern jaws (e.g., the fate of the incus). Our results might provide a conceptual framework for the rise of
jaw morphotypes characteristic of gnathostomes.
Citation: Vieux-Rochas M, Coen L, Sato T, Kurihara Y, Gitton Y, et al (2007) Molecular Dynamics of Retinoic Acid-Induced Craniofacial Malformations:
Implications for the Origin of Gnathostome Jaws. PLoS ONE 2(6): e510. doi:10.1371/journal.pone.0000510
INTRODUCTION
Retinoic acid (RA), the active metabolite of vitamin A, is
indispensable for normal morphogenesis and organogenesis of
most vertebrate species. When administered during embryonic
development, RA also acts as a potent teratogen in all vertebrates
and even in certain invertebrates [1–3]. The spectrum of RA-
induced malformations is highly variable depending on the dose
administered and on the developmental stage at the time of
exposure [1–3]. In humans, oral intake of RA during the first
weeks of pregnancy engenders highly variable morphological and
neural lesions collectively named ‘‘retinoic acid embryopathies’’
(RAEs); these include severe defects of the jaws and of the middle
and external ear [4–7]. In the mouse, treatment of pregnant
females or cultured embryos with RA at embryonic day (E) 8.0
induces fusion and hypoplasia of the first two pharyngeal arches
(PAs). These embryonic defects could well account for the
craniofacial alterations displayed at birth upon RA exposure.
Indeed, most of the structures affected derive from the 1st and 2d
PAs, which are colonized by incoming cranial neural crest cells
(CNCCs) [8–14]. It has been repeatedly proposed that CNCCs
could be the primary target of RA-induced teratogenesis of facial
structures [15–19]. This notion derived from the fact that most
dysmorphic structures in RAE are CNCC derivatives and was
reinforced by initial analyses of animal models suggesting that
excess RA could alter CNCC survival and migration [20,21].
Recent studies, however, have shown that retinoid-induced
fusion of the 1st and 2d PA occurs without any obvious alteration of
CNCC migration or apoptosis [16]. More importantly, it has been
shown that CNCCs colonizing the first two PAs do not express
a retinoid responsive transgene upon treatment with a general
agonist of RA. This finding clearly indicates that the RA-mediated
transduction machinery is not active in these cells shortly after
their arrival in the PAs [22]. These notion is also supported by
reports showing that CNCCs, although expressing certain RA
nuclear receptors [23,24], may not respond directly to RA under
physiological conditions [25–28]. CNCCs do not seem, therefore,
to be the primary targets of RA-induced defects in derivatives of
the 1st PA.
Recent, grafting and fate mapping experiments have un-
equivocally shown that molecular signals deriving from the
endodermal and ectodermal epithelial linings of the 1st PA, are
essential for patterning the underlying neural crest-derived
ectomesenchyme [29,30]. Indeed, the epithelial lining of the 1st
PA is endowed with a molecular map which conveys to CNCCs
the information needed to generate craniofacial structures [29,30].
These observations suggest that a possible target of RA activity
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could be the PA epithelia and that RA treatment would result in
an alteration of their signals to CNCCs.
This hypothesis finds support in recent findings showing that
treatment of mouse embryos with a general agonist of RA,
activates ectopic RA signalling in the endoderm and ectoderm
lining the first two PAs. This change in epithelial patterning is
revealed by the rostral shift of the expression domains of RA-
responsive genes including the Rarehsp68-lacZ reporter, the RARß
gene, Hoxa1 and Hoxb1 [22]. Indeed, Hox expression seems to play
an important role in the regionalization of the pharyngeal
endoderm [28,31,32] a developmental function that can occur
even in the absence of CNCCs [3,33–35].
Taken together, these data might suggest that the craniofacial
defects of RAE all derive from an abnormal signalling function of
the pharyngeal epithelium to CNCCs. However, the exact
mechanism underlying this action of RA, and its impact on the
development and evolution of craniofacial structures remains so
far unexplained.
At variance from what happens in the other PAs, CNCCs
colonizing the 1st PA do not express Hox genes [36] and their
patterning depends on the expression of several families of non-
Hox homeobox genes. In particular, Dlx genes, homeodomain
transcription factors related to drosophila dll, play a pivotal role in
determining mandibular and maxillar identities [37–40]. Dlx1 and
Dlx2 are activated in CNCCs by Fgf8 from a signalling center in
the 1st PA ectoderm [41–44], their targeted inactivation engenders
mostly maxillary arch defects with the appearance of a cartilagi-
neous structure positionally homologous to a palatoquadrate (pq)
[38]. Conversely, Dlx5 and Dlx6 are activated in CNCCs by ET1
signalling from the 1st PA endoderm [45,46] and their targeted
inactivation leads to the transformation of the lower jaw into an
upper jaw with loss of Meckel’s cartilage (Mc) and the appearance,
in the lower jaw, of maxillary arch derivatives such as the vibrissae
and palatine rugae [39,47]; mice lacking ET1 or its receptor A
(ETRA) present a similar transformation [46,48]. Therefore, on
the basis of their nested expression pattern and of the craniofacial
phenotypes of the corresponding mutant mice, it has been
proposed that Dlx genes play a pivotal role in determining the
patterning, development and evolution of vertebrate jaws [40].
In this study we explored the possibility that the craniofacial
lesions present in RAE could derive from altered signalling from
the PA epithelium leading to abnormal activation of Dlx genes in
CNCCs. Our observations fully confirm this hypothesis and
prompt us with new insight suggesting a possible scenario for the
origin of craniofacial structures in vertebrates.
RESULTS
Timing of RA teratogenic effects on craniofacial
structures
We first analyzed the chondrocrania (14.5 dpc) and the derma-
tocrania (18.5 dpc) of mouse embryos from pregnant females that
had received a single dose of RA by force-feeding (gavage). This
single treatment was administered at different times within
a narrow temporal window, which encompassed the period of
CNCC colonization of the PAs. RA administration had the most
pronounced effects on craniofacial structures in an interval
ranging from 204 to 213 hours post coitum (hpc) (9 to 14 somites,
corresponding to 8.5–8.75 dpc). This is the period during which
CNCCs from rhombomeres 1 and 2 and the mesencephalon reach
the 1st PA [11]. No major defects in craniofacial structures were
observed when the treatment was administered either before
202 hpc or after 215 hpc. The phenotypes obtained were variable
even within a single litter, possibly due to different times of
individual fertilizations and hence to the different age of individual
embryos. In spite of this, by comparing the spectrum of
phenotypes displayed by embryos issued from more than 40
timed-litters we were able to arrange the dysmorphologies induced
by RA in an unequivocal sequential order. Here we only focus on
the skeletal phenotypes, but a detailed description of other aspects
of the phenotype, including an analysis of non-skeletal structures,
will be presented elsewhere.
Dynamics of chondrocranial defects induced by RA-
treatment of mouse embryos
In the chondrocrania (Figures 1, 2; Figure S1), the first defects to
appear were proximal malformations of Meckel’s cartilage (Mc),
reminiscent of the phenotype of Dlx5 single mutants [37]. First,
a medially-oriented bend appeared close to the junction between
the proximal part of Mc and the malleus (Figure 1, Figure S1 and
Figure 1. Schematic drawings representing the main features of the
chondrocrania (14.5 dpc) of embryos which received a single RA
pulse at the indicated developmental time (expressed in hours post
coitum). Left column, lateral view; right column, caudal view. The main
structures highlighted in colour are Meckel’s cartilage (Mc, red), the
neoformed palatoquadrate (pq, yellow), the ala temporalis (at, green),
and the stylo-hyoidiean cartilage (sh). The first defect to develop is
a proximal deformation of Mc with the appearance of a medially
oriented cartilage bar. The malleus (m) is rapidly lost. Then the pq and
the sh appear at the same time. The distal part of Mc separates,
shortens progressively and eventually disappears. The pq becomes
progressively more prominent, to occupy most of the maxillary region
of the head. Coincidentally with the appearance of the pq, the at is
duplicated (at*) and later triplicated (at**). Treatment of embryos of
211–213 hpc leads to a complete loss of Mc and of the pq.
doi:10.1371/journal.pone.0000510.g001
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Figure 2G–L). With RA treatments performed at later times (204–
210 hpc), this bend became progressively more pronounced
resulting in a medially-oriented cartilage bar extending from the
residual malleus towards the midline and a distal part of Mc which
fused at the distal-most end of the lower jaw (Figure 1, Figure 2G–
I). These distal Mc segments eventually detached from the
proximal horizontal cartilage bar, became progressively smaller
and made contact, through their proximo-dorsal aspect, with the
ala temporalis. When RA treatment was performed between 212
and 214 hpc the Mc was reduced to its distalmost part and then
disappeared (Figure 2K, L), these phenotypes resemble those
observed in Dlx5/Dlx6 combined mutant mice [39,47] and in mice
mutant for either ET1 or ETRA [46,48]. Treatments performed
at later times resulted in an almost normal development of Mc
with only mild proximal defects (data not shown).
During development of the middle ear in mammals, the malleus
derives from the most proximal part of Mc and normally contacts
the incus. The mammalian incus is considered to be the last
reminiscence of the palatoquadrate, a large cartilage bar present in
the upper jaw of reptilians and fish. Concomitantly with the
Figure 2. Defects of the chondrocranium induced by RA treatment at different developmental times. Lateral (A–F) or caudal (G–H) views of
chondrocrania of representative 14.5 dpc embryos stained in alcian blue to reveal cartilagineous structures. The embryos derive from control
mothers treated with vehicle alone (G, M, P), or from mothers exposed to a single dose of RA at 203 (A, H), 204 (B, I), 206 (C, J), 208 (K), 210 (D), 211 (E,
F) and 212 (L) hpc (+/21). Detailed views of the middle ear cartilages (M–O) and of the region of the at (P–S) in 14.5 dpc control embryos (M, P) and in
embryos deriving from mothers exposed to a single dose of RA at 203 (N), 204 (O), 206 (Q), 210 (R) and 212 (S) hpc (+/21). Early RA treatment (A, B, N)
results in the progressive deformation of the incus (in, green asterisk in N, O) which elongates rostrally making initially contact with the proximal part
of Meckel’s cartilage (Mc) (B, N). Then the deformed incus makes contact with a new cartilage bar forming in the maxillary region (red arrow in O) and
gives rise to a cartilagineous structure that occupies the same relational position as the palatoquadrate (pq) in a generalized gnathostome. Later
treatments result in the formation a long flattened cartilagineous palatoquadrate in the maxillary region (D–F, J, K), this structure could be duplicated
at the distalmost end (E) or appear as two parallel, highly anastomosed cartilage bars (F). Early RA treatments resulted in proximal defects of Mc with
displayed a proximo median deformation (black arrows in H,I). With late treatments, Mc separates into a proximal part which generates a longitudinal
bar oriented medially and a distal part which detaches, from the proximal region (J) and persists as strongly reduced distal structure (K); finally, Mc,
completely disappears when the RA treatment is performed after 209 hpc (black asterisk in D, E, F, L indicates the absence of Mc in the lower jaw). In
parallel, the at duplicates longitudinally (P, Q, R) and, with later treatments, appeared to be triplicated (S, red asterisks indicate the duplicated at).
Finally a new cartilaginous connection between the styloid process (s) and the hyoid cartilage formed as soon as proximal defect of Mc could be
detected (B–E; H–K, N,O); this structure resembles closely the stylo-hyoı¨do connection (sh) present in other species. No major defects where induced
by RA treatments at this stages in other structures such as the sphenoid cartilage (sp) or the otic capsule (oc).
doi:10.1371/journal.pone.0000510.g002
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appearance of proximal Mc defects, we observed a severe mal-
formation of the malleus, which eventually detached from the Mc
and disappeared. At the same time, the incus elongated towards
the distal end of the upper jaw and contacted the proximal part of
Mc with which it either formed an articulation or it anastomosed
(Figure 2A–C). A cartilage condensation appeared in the center of
the lateral aspect of the upper jaw, it extended progressively at
both ends to occupy most of the length of the jaw contacting the
defective incus with its proximal part (Figure 2D–F; M–O). This
process resulted in a large, transversely flattened, bar that occupied
much the same position relative to Mc and the braincase as the
palatoquadrate of non-mammalian vertebrates (as in Dlx1/2
mutants [38]) (Figure 1; Figure 2D–F, J, K; Figure S1). In the
rest of this study we will refer to this structure as ‘‘palatoquadrate’’
(pq). In its most developed forms, the pq was constituted by two
closely anastomosed parallel cartilage bars (Figure 2F; Figure 3
210 hpc), suggesting a mirror duplication (predicted in [40] for the
quadruple inactivation of Dlx1/2/5/6, but never demonstrated
yet), this cartilaginous structure persisted until birth.
The ala temporalis, another maxillary derivative, was duplicat-
ed by early RA treatments (203–206 hpc) (Figure 2P–R) similarly
to what is observed in Dlx5/Dlx6 combined mutant mice;
treatment at later time points resulted in the triplication of the
ala temporalis (Figure 2S) which eventually disappeared with even
later treatments. Starting with RA treatments at 208 hpc we
observed the appearance of a cartilage structure connecting the
hyoid cartilage and the styloid process (Figure 1, Figure 2N, 0).
This cartilage connection, present in many vertebrates, will be
referred to as the stylo-hyoid cartilage (sh). With later treatments,
the sh included a lateral branching toward the larynx. RA
treatments performed around 212 hpc resulted in the complete
loss of most distal craniofacial components including the Mc and
the pq (Figure 4; Figure 5L).
Dynamics of dermatocranial defects induced by
RA-treatment of mouse embryos
In the dermatocrania of RA-treated embryos (Figures 3, 4 and
Figure S2), the dentary was progressively reduced and transformed
into maxillary-like elements (Figure 4 A–E) as observed in mutants
of the ET1RETRARDlx5/6 pathway [39,46–48]. Early RA
treatments (203–205 hpc) resulted in the loss of the angular and
Figure 3. Defects in the dermatocranium induced by RA treatment. Right column represents the lateral view of representative dermatocrania
obtained after RA treatment at the indicated developmental times (expressed in hpc). The second and third columns are a series of drawings
representing the main features of the dermatocrania (18.5 dpc) of the same embryos. Central column, lateral view; right column, caudal view. The
main structures highlighted in colour are: the dentary (dt, red), the palatoquadrate (pq, yellow), the derivatives of the maxillary component of the 1st
PA (green) and the tympanic ring (tr). Note the progressive transformation of the dentary starting at 205 hpc (arrows at this stage indicate the
duplicated jugal bones) accompanied by the appearance of an increasingly large palatoquadrate (pq) which, in embryos treated 210 hpc, appears as
two closely anastomosed parallel bars. Note also the disappearance of the tympanic ring, the opening of the palate, the deformation of the maxillary
complex and of the pterygoid bone.
doi:10.1371/journal.pone.0000510.g003
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coronoid processes and in the progressive deformation of the
condylar process, which extended laterally and dorsally and
contacted (and later fused) with the jugal bone of the maxillary
arch (Figure 4F–H). Later RA treatments resulted in the loss of all
the proximal part of the dentary including the molar and its
alveolus. This profoundly deformed dentary fused dorsally with
the zygomatic process of the maxilla (Figure 3; Figure 4I; Figure
S2C). Furthermore, with late RA treatments, the remnants of the
dentary were connected to a new bony plaque, which appeared in
the upper jaw over the large cartilaginous and ramified palato-
quadrate (Figure 3; Figure S2C). Late RA treatments resulted in
the formation of a stylo-hyoid cartilage, which could also form
a lateral branching giving rise to a laryngo-hyoidiean connection.
The distalmost part of the dentary always persisted as a tubular
structure, carrying an incisor, somehow reminiscent of a pre-
maxillary bone (Fig 4D, E, J). In the most extreme cases the right
and left remnants of the dentary fused medially to give a single
medial tubular structure carrying a single incisor (Figure 4E). The
distinct abnormal shapes of the dentary resulting from RA
treatments were closely reminiscent of those observed in newborn
mice in which multiple alleles of Dlx genes are inactivated [40].
Finally, the tympanic ring was lost coincidentally with the
appearance of a pq. The palate did not close, and the pterygoids
were flattened and extended medially (Figure S3).
Figure 4. Defects of the dentary induced by RA treatment at different
developmental times. Caudal (A–E) and lateral (F–J) views of dentary
bones dissected from 18.5 dpc control embryos (A, F) or from embryos
deriving from mothers exposed to a single dose of RA at 205 (B, G), 206
(H), 208 (C), 210 (D, I), 212 (J) and 213 (E) hpc (+/21). The main features
which can be recognized are the coronoid process (CoP), the condylar
process (CnP), the angular process (An), the molar alveolus (MA) and the
incisive (i). Early RA treatment results in shortening of the dentary with
gradual loss of the CoP and of the An. At the same time, the CnP
extends towards the upper part of the skull and contacts (or even fuses)
with the jugal bone (B,G,H, see also Figure 6). Later RA treatments result
in a dramatic reduction of the dentary which becomes a small tubular
distal structure carrying an incisor. This vestigial dentary has lost all
process and the MA (C–D; I,J); in the most severe cases the right and left
remnants of the dentary fuse medially to give rise to a single, medially-
located, tubular structure carrying a single incisor (E).
doi:10.1371/journal.pone.0000510.g004
Figure 5. Effect of RA treatment on the specification of the maxillary
and mandibular arch. (A) Pregnant B6D2F1xDlx5lacZ/+ mice received by
gavage a single dose of RA or vehicle, 207 hours after coitum. Embryos
were collected 2 days later and the expression of Dlx5-lacZ was
revealed by Xgal staining. RA treatment induced the selective down
regulation of Dlx5-lacZ expression in the 1st PA (arrow) and did not
affect its expression in other territories including the other PAs, the limb
apical ectodermal ridge (arrow head), the otic vesicle (ov) and the
olfactory placode. A similar result was obtained when analyzing the
expression of Dlx5 in normal embryos treated with RA at the same time
(data not shown). (B) Transgenic mice in which the expression of lacZ is
driven by the Dlx5/Dlx6 intragenic enhancer I56i, were treated with
a single dose of RA or vehicle as described above. In treated embryos
collected 2 days later, expression of the reporter gene was selectively
lost in the 1st PA (arrow), but persisted in the brain and in the other PAs.
(C) RA treatment of pregnant normal mice 207 hours after mating leads
to a reduced expression of Dlx6, Dlx1, Dlx2 and of dHAND (a target of
Dlx5 and 6) in the 1st PA of embryos collected at 10.5 dpc. (D)
Transformation of the lower jaw induced by RA treatment. 14.5 dpc
Krox20-lacZ+/2 heterozygous embryos deriving from a mothers which
had received either a single gavage of RA at 207 hpc (two
representative littermates are shown, RA right panels) or vehicle alone
(control: left panel) were stained with Xgal to reveal the formation of
vibrissae. Note the appearance of rows of vibrissae in the lower jaw
(white arrow), indicating a transformation into an upper jaw territory.
The number of vibrissae in the lower jaw was highly variable even
between littermates.
doi:10.1371/journal.pone.0000510.g005
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RA-treatment of mouse embryos leads to the
progressive loss of expression of Dlx genes and to
the transformation of the 1st PA
The craniofacial defects induced by RA treatment are reminiscent
of those obtained by the combinatorial inactivation of Dlx alleles
by gene targeting in the mouse [40].
We monitored the effects of RA treatment on the expression of
Dlx genes and their targets. At 10.5 dpc, about 48 hours after the
RA pulse, the expression of Dlx1, Dlx2, Dlx5, Dlx6 and the known
downstream target dHAND [45] was strongly reduced in the 1st PA
(Figure 5A, C), but was not obviously affected in other structures.
This effect was reminiscent of what we previously observed in
Danio rerio [49]. The reduction of expression of Dlx5, Dlx6 and
dHAND was invariably more pronounced in the proximal part of
the 1st PA, while that of Dlx1 and Dlx2 was more evenly affected.
These inhibitory effects were highly variable even among
littermates (Figure S3 and data not shown).
We then analyzed the effects of RA on the activation of I56i,
a well characterized evolutionary-conserved enhancer located in
the Dlx5-6 intergenic region [50]. This enhancer is involved in
ET1 signal transduction (Kurihara, unpublished observations).
Treatment of pregnant I56i-lacZ mice with RA in the critical
period described above, specifically inhibited the enhancer activity
in the 1st PA leaving it unaffected in the brain and in other PAs
(Figure 5B and Figure S3) supporting the notion that RA
treatment affects the ET1-mediated activation of Dlx5/6 through
enhancer I56i.
The combined inactivation of Dlx5 and Dlx6 in the mouse leads
to a lower-to-upper jaw transformation, with vibrissae forming also
in the lower jaw [39,40]. In order to see if a similar transformation
was taking place following the reduced expression of Dlx5 and 6 in
the 1st PA of RA-treated embryos we analyzed the effects of RA on
Krox20-lacZ+/2 mice, in which the lacZ reporter is expressed by the
developing vibrissae [51]. When pregnant Krox20-lacZ+/2 mice
were treated with RA, vibrissae pads appeared ectopically in the
lower jaw of 14.5 dpc embryos (6 days after treatment) (Figure 5D)
indicating that the lower-to upper jaw transformation had indeed
taken place.
RA treatment leads to a reduction of the territories
of Fgf8 and ET1 expression in the epithelium of the
1st PA
In the 1st PA Dlx genes are mostly expressed by the mesenchyme
derived from CNCCs. Given the timing of treatment and the
absence of RARs in CNCCs, the reduced expression of Dlx genes
could result from an altered production of their known inducing
molecules by the 1st PA signalling centers: ET1 and Fgf8. We
analyzed embryos 4 hours after RA treatment, and we observed
a clear reduction in the territory of ET1 and Fgf8 expression within
the 1st PA epithelium (Figure 6). Notably this effect appears to be
specific for the 1st PA, as the expression of Fgf8 in the isthmus of
the same embryos was unaffected by exposure to RA.
DISCUSSION
In this study, we provide an explanation for the origin of
craniofacial malformations induced by RA exposure. We show
that one single RA treatment of pregnant mice carrying embryos
of 8.5–8.75 dpc results in a series of craniofacial defects affecting
most of the 1st PA. The developmental stage at which RA
treatment of the mother results in craniofacial malformations is
204 to 213 hpc i.e. embryos of 9 to 14 somites. This is the window
of time during which CNCCs from rhombomeres 1 and 2 and the
mesencephalon reach the 1st PA [11]. When analyzing the
chondrocrania or the dermatocrania of treated embryos, we
observe that the defects deriving from the earlier treatments affect
only proximal derivatives of the 1st PA such as the proximal part of
Mc or the malleus, while treatments performed at later times affect
both proximal and distal structures. These morphological defects
are mirrored by the progressive reduction of the territories of Dlx
gene expression which is first reduced only in proximal parts of
the 1st PA and then progressively lost from most of the 1st PA,
persisting always only in the distalmost region. Most of the defects
induced by RA treatment can be interpreted as the direct
consequence of the progressive reduction in the level of expression
of Dlx genes. Indeed, similar defects are observed either in mice in
which Dlx genes have been inactivated [37–40] or in mice carrying
different Dlx allelic combinations obtained by cross breeding
different mutants [40].
In the 1st PA Dlx genes are expressed by incoming CNCCs only
in response to molecular signals emanating from the PA epithelial
lining. Dlx5 and Dlx6 are activated by ET1 secretion from the
pharyngeal endoderm [45,46]. Inactivation of either ET1 or its
receptor A completely inhibit their expression in the underlying
ectomesenchyme [46,48]. Dlx1 and Dlx2 are activated in the
ectomesenchyme by Fgf8 secreted from the epithelium of the 1st
PA [42,43]. Our results indicate that RA-mediated repression of
Dlx genes in CNCCs is not direct. First, we show that after RA-
treatment, Dlx genes are selectively downregulated in the 1st PA,
but not in other PAs or in other structures such as the otic vesicle
or the limbs. This suggests that this regulation does not reflect
a generalized effect of RA. Second, concerning more specifically
Dlx5 and Dlx6 we show that their RA-repression is mediated
through I56i a well characterized enhancer which does not contain
retinoic acid responsive elements [50] and which is activated by
ET1. The defective expression of Dlx genes in the mesenchyme of
the 1st PA and the morphological effects of RA treatment could
derive from the reduction Fgf8 and ET1 signalling from the 1st PA
epithelium to CNCCs. However, in the absence of direct rescue
experiments, excessively difficult in the early mouse embryo, the
Figure 6. Reduction of the territories of expression of Fgf8 and ET1
induced by RA treatment in the 1st PA. In situ hybridization with an
Fgf8 and an ET1 probe on the head region of normal embryos collected
4h after treating the mother with vehicle or RA at 207 hpc. Note that
the territory of expression of both genes in the signalling territory of the
epithelium of the 1st PA (black arrow) is strongly reduced, while the
level of expression of Fgf8 in the isthmus (is) was not significantly
affected by RA treatment.
doi:10.1371/journal.pone.0000510.g006
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contribution of ET1 and Fgf8 pathways on RA-induced
craniofacial malformations remains still to be directly demonstrat-
ed. To circumvent this difficulty we are reproducing a similar
analysis on other vertebrate species (chick, Xenopus) in which
localized rescue experiments can be designed more easily. In any
event, the ET1RETRARDlx5/6 and the Fgf8RDlx1/2 path-
ways do not seem to be mutually interacting as their genetic
perturbation by gene targeting in the mouse leads to distinct and
non overlapping phenotypes: the first results in the transformation
of the lower jaw in an upper jaw, the second in the appearance of
a pq (summarized in Figure 7).
As mentioned in the introduction, two further sets of data
reinforce the notion that the lesion induced by RA in the specific
window of time we have chosen, depends on altered signalling
from the pharyngeal epithelia. First of all grafting experiments in
the chick have demonstrated the critical importance of endoder-
mal and ectodermal signalling for patterning CNCCs [29,30].
Second, recent findings show that treatment of mouse embryos
with a general agonist of RA, activates ectopically RA signalling in
the endoderm and ectoderm lining the first two PAs [22]. In this
same study it is clearly shown that RA cannot elicit a RA-receptor
mediated response in CNCC at this stage of development.
Many experimental indications support the notion that the
teratogenic effects of retinoids are receptor-mediated. First of all,
those synthetic retinoids which are incapable to activate retinoic
acid receptors (RARs) are not teratogenic [52], whereas
administration of agonists for different RAR isotypes results in
isotype-specific congenital defects [53,54]. Second, mouse embry-
os lacking either RARc or RXRa are resistant to many RA-
induced malformations [55–58], whereas inactivation of RARc
restores the viability of mice lacking the RA-degrading enzyme
CYP26A1 [59]. The physiological roles of endogenous RA in the
control of developmental processes do not seem to be generally
reflected by the teratogenic effects resulting from administration of
exogenous RA to embryos. Indeed, RA can lead to teratogenic
effects at stages where RA is not normally synthesized in the
embryo [60] and the spectrum of malformations induced by excess
of RA are different from those observed in mice in which RA
signalling has been genetically or pharmacologically impaired
[61–64].
RA-dependent inactivation of the ET1 pathway might involve
RARß/RXR heterodimers, which are induced in the endoderm
and are known to act as ET1 suppressors [22,65]; inactivation of
Fgf8 expression could involve RARa [66].
Our results reinforce the notion that the exact topography and
timing of epithelial signalling to CNCC is essential to determine
different craniofacial morphotypes [42]. In particular, our findings
imply that for normal craniofacial development of the mouse it is
essential to protect specific signalling regions of the 1st PA from the
action of RA. Remarkably, the RA-degrading enzymes CYP26A1
and CYP26C1 are expressed in these regions when CNCCs reach
the 1st PA [67,68].
Depending on the exact age of the embryo at treatment, we
have observed the co-variance of several craniofacial characters
leading to morphologies that somewhat recall the primitive
condition of jawed vertebrate skulls where the palatoquadrate is
separate from the braincase. A particularly vivid example can be
seen at the level of the inner ear. The progressive transformation
of the incus into a pq (caused by the loss of Dlx1/2) is paralleled by
that of the malleus into the proximal part of Mc (caused by the loss
of Dlx5/6). These two simultaneous transformations generate an
articulation between the proximal part of the transformed Mc and
the pq. This articulation is a typical character of primitive jaws,
which, in modern gnathostomes, persists between the malleus and
the incus. Furthermore the co-variance of other characters, such as
the appearance of a sh connection can be regarded as an example
of how mutations affecting the regulation of an early morphoge-
netic process can lead to the co-evolution of many characters of
the same organism, that are presumed not to be functionally
related.
Similar mechanisms might have been more generally involved
in determining the development and evolution of animal form and
could account for what is often depicted as bursts of anatomical
innovations in evolutionary scenarios.
METHODS
Experimental Procedures
Mice Normal B6D2F1 hybrid mice (Charles River Laboratory,
France) 9 to 28 weeks old were used throughout this study.
Generation and genotyping of the Dlx5LacZ/+, Dlx5/Dlx6neo/+,
Krox20LacZ/+, Et1neo/+ have been previously described
[37,39,51,69], these mutations were maintained on the B6D2F1
hybrid genetic background. Lines of transgenic mice expressing
lacZ under the control of the mouse I56i enhancer were previously
described [50]. For timed mating, male and female mice were
placed in the same cage at 7 pm (1 hour before light extinction),
vaginal plugs were detected at 9 pm and the mice were then
separated, 8 pm was considered as the average mating hour. For
non-timed mating, mice were left together through the night and
vaginal plugs were detected at 9 am next morning.
RA administration We treated mouse embryos by gavage of
the mother with RA at precise times after mating. This approach,
largely used to study the effects of RA on axial skeletal development,
has been difficult to apply to the analysis of craniofacial
abnormalities due to complex and variable phenotypes observed
even among littermates. To chose the window of time most appro-
priate to study craniofacial malformations we made reference to
previous reports. Treatments of mouse embryos between 7 and
8 dpc are known to result in severe axial defects including vertebral
and CNS transformations [70,71] with no major effects observed on
craniofacial structures. Most craniofacial effects have been observed
with treatments performed shortly after this period [71,72], however
the defects observed were very variable and a detailed description of
the lesions is still missing. To better control the time of RA exposure,
we systematically administered a single dose of RA at times after
mating ranging from 200 to 224 hours post coitum (hpc). As after
oral administration RA is quickly degraded [73], this protocol results
in exposing embryos to pharmacological levels of RA for less than
2 hours. We then analyzed the effects of this early RA exposure in
10.5, 14.5 and 18.5 dpc embryos, therefore approximately 2, 6 and
10 days after treatment.
A solution of all-trans-retinoic acid (Sigma, France) (25 mg/ml
in dimethylsulphoxide) was diluted l/10 in olive oil just before use,
and about 0.3 ml were delivered by a single gavage for a final dose
of 25 mg/Kg of maternal body weight. The gavage was performed
on the 8th dpc at times varying between 6 am and 9 pm. Control
mice received the same mixture without RA. To collect embryos
at 10.5, 14.5 and 18.5 dpc pregnant mice were anesthetized and
sacrificed by cervical dislocation at 12 am of the corresponding
day. To detect the direct effect of RA on gene expression of Fgf8
and ET-1 mice embryos were collected 4h after gavage.
Whole-mount RNA in situ hybridization RNA in situ
hybridation was performed using a digoxigenin (DIG)-UTP
(Roche) labelled antisense RNA probe. Signal was detected
using an alkaline-phosphatase-conjugated anti-DIG antibody and
NBT/BCIP substrate (Roche). Whole mount hybridisation was
carried out as described [46] with slight modifications.
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The dHand probe corresponded to 450 bp in the 39 end of dHand
cDNA and was linearized with EcoRI and transcribed with T7
RNA polymerase. The Dlx1 probe comprised 720 bp of the 39 end
of murine Dlx1 cDNA and was linearized with BamHI and
transcribed with T7 RNA polymerase. The Dlx5 probe comprised
780bp and was linearized with EcoRI and transcribed with T7
Figure 7. Summary diagram of the effects of RA on derivatives of the 1st PA. (A) RA treatment (right side) inhibits both Fgf8 (blue) and ET1 (green)
signalling from the 1st PA epithelium and gradually prevents the activation of Dlx1/Dlx2 (yellow) and Dlx5/Dlx6 (red) in the CNCC-derived
ectomesenchyme. This results in phenotypic combinations of altered characters reminiscent of those present in the Dlx1/2 and Dlx5/6 double
mutants. (B) Summary diagram of the effects of RA-treatment during jaw development.
doi:10.1371/journal.pone.0000510.g007
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RNA polymerase. The Dlx6 probe comprised 370bp and was
linearized with SpeI and transcribed with T7 RNA polymerase.
The Et1 probe corresponded to 1000bp of mouse Et1 cDNA ORF
and was linearized with ApaI and transcribed with Sp6 RNA
polymerase. The Fgf8 probe comprised 800bp of the 39 UTR and
the entire coding region of a spliced variant of mouse Fgf8; it was
linearized with PstI and transcribed with T7 RNA polymerase.
Skeletal Preparations Cartilage staining of E14.5 embryos
as well as bone and cartilage staining of E18.5 embryos were
carried out as previously described [37].
b-galactosidase staining For lacZ expression analysis
10.5 dpc embryos were fixed for 15–30 min in 2%
paraformaldehyde (PFA) in PBS, while 14.5 dpc embryos were
fixed for 15–30 min in 4% PFA. Xgal staining was performed as
described [37].
SUPPORTING INFORMATION
Figure S1 Chondrocranial defects induced by RA. Lateral (right)
and caudal (left) views of the chondrocrania of representatice
14.5 dpc embryos stained with alcian blue. The embryos derive from
litters obtained after treatment of the pregnant mother at the
indicated developmental time (expressed in hours post coitum). Black
arrow: Meckel’s cartilage, red arrow: palatoquadrate.
Found at: doi:10.1371/journal.pone.0000510.s001 (8.01 MB TIF)
Figure S2 Defects in the base of the dermatocranium induced
by RA treatment. Images of the base of the skull of skeletal
preparations from a 18.5 dpc control embryo (A) or from embryos
deriving from mothers exposed to a single dose of RA at 205 (B) or
210 (C) hpc. With early RA treatments (B), the proximal part of
the dt is lost, later treatments (C) result is a dramatic reduction of
the dt which is reduced to a small distal part which is connected to
a new bony plaque which appears in the upper jaw over the large
cartilagineous palatoquadrate (pq). RA treatments result in the
formation of a stylo-hyoidiean connection (sh), which, with later
treatments, forms also a lateral branching giving rise to a laryngo-
hyoidiean connection (Lh). Abbreviations: dt: dentary, tr,
tympanic ring; hy, hyoid bone; oc, otic capsule, sh stylo-hyoidiean
connection; Lh, laryngo-hyoidiean connection.
Found at: doi:10.1371/journal.pone.0000510.s002 (6.53 MB TIF)
Figure S3 Variability of RA effects on gene expression in the 1st
PA even between littermates. I56i-lacZ embryos at 10.5 dpc
deriving from a litter treated with a single pulse of RA at 207 hpc.
In all cases we observe a reduction of the territory of expression of
the reporter gene in the 1st PA (arrow), but not in other positive
structures such as the brain (br) or other PAs. On the right,
a control embryo issued from an untreated litter.
Found at: doi:10.1371/journal.pone.0000510.s003 (4.28 MB TIF)
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